| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Conditioning Regimen with Plerixafor Is Safe and Improves the Outcome of TCRαβ+ and CD19+ Cell-Depleted Stem Cell Transplantation in Patients with Wiskott-Aldrich Syndrome
|
Balashov, Dmitry
|
|
2018
|
24 |
7 |
p. 1432-1440
|
artikel
|
| 2 |
ASBMT Notes
|
|
|
2018
|
24 |
7 |
p. 1530-1531
|
artikel
|
| 3 |
Association between Activated Partial Thromboplastin Time and the Amount of Infused Heparin at Bone Marrow Transplantation
|
Kusuda, Machiko
|
|
2018
|
24 |
7 |
p. 1367-1371
|
artikel
|
| 4 |
Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy
|
Cowan, Andrew J.
|
|
2018
|
24 |
7 |
p. 1386-1391
|
artikel
|
| 5 |
Clinical Impact of Pretransplant Multidrug-Resistant Gram-Negative Colonization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
|
Forcina, Alessandra
|
|
2018
|
24 |
7 |
p. 1476-1482
|
artikel
|
| 6 |
Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor–Enriched Cord Blood, to Double Cord Blood Unit Transplantation
|
Stiff, Patrick J.
|
|
2018
|
24 |
7 |
p. 1463-1470
|
artikel
|
| 7 |
Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives—A Single-Center Experience, 2008 to 2016
|
Yanir, Asaf D.
|
|
2018
|
24 |
7 |
p. 1424-1431
|
artikel
|
| 8 |
Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study
|
Picod, Adrien
|
|
2018
|
24 |
7 |
p. 1471-1475
|
artikel
|
| 9 |
Donor Cell–Derived Hematologic Neoplasms after Hematopoietic Stem Cell Transplantation: A Systematic Review
|
Suárez-González, Julia
|
|
2018
|
24 |
7 |
p. 1505-1513
|
artikel
|
| 10 |
Early Blood Stream Infections after BMT are Associated with Cytokine Dysregulation and Poor Overall Survival
|
Catchpoole, Elizabeth M.
|
|
2018
|
24 |
7 |
p. 1360-1366
|
artikel
|
| 11 |
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia
|
Shah, Mithun Vinod
|
|
2018
|
24 |
7 |
p. 1514-1520
|
artikel
|
| 12 |
Editorial Board
|
|
|
2018
|
24 |
7 |
p. A6
|
artikel
|
| 13 |
Epstein-Barr Virus-Related Post-Transplantation Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation
|
Liu, Li
|
|
2018
|
24 |
7 |
p. 1341-1349
|
artikel
|
| 14 |
Get Outta Here! Addition of Mobilizing Agents to Conditioning Regimen Improves Donor Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation for Wiskott-Aldrich Syndrome
|
Rettig, Michael P.
|
|
2018
|
24 |
7 |
p. 1309-1311
|
artikel
|
| 15 |
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison
|
Devillier, Raynier
|
|
2018
|
24 |
7 |
p. 1449-1454
|
artikel
|
| 16 |
Impaired Bone Mineral Density in Pediatric Patients with Chronic Graft-versus-Host Disease
|
Buxbaum, Nataliya P.
|
|
2018
|
24 |
7 |
p. 1415-1423
|
artikel
|
| 17 |
Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT
|
Shenoy, Shalini
|
|
2018
|
24 |
7 |
p. 1313-1321
|
artikel
|
| 18 |
Long-Term Results of Prophylactic Donor Lymphocyte Infusions for Patients with Multiple Myeloma after Allogeneic Stem Cell Transplantation
|
Gröger, Maximilian
|
|
2018
|
24 |
7 |
p. 1399-1405
|
artikel
|
| 19 |
Low CD34+ Cell Doses Are Associated with Increased Cost and Worse Outcome after Tandem Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Germ Cell Tumors
|
Hyder, Mustafa A.
|
|
2018
|
24 |
7 |
p. 1497-1504
|
artikel
|
| 20 |
Masthead (Purpose and Scope)
|
|
|
2018
|
24 |
7 |
p. A4
|
artikel
|
| 21 |
Officers and Directors of ASBMT
|
|
|
2018
|
24 |
7 |
p. A7
|
artikel
|
| 22 |
Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma
|
Garderet, Laurent
|
|
2018
|
24 |
7 |
p. 1372-1378
|
artikel
|
| 23 |
Pharmacokinetic and Pharmacodynamic Markers of Mycophenolic Acid Associated with Effective Prophylaxis for Acute Graft-Versus-Host Disease and Neutrophil Engraftment in Cord Blood Transplant Patients
|
Yoshimura, Kazuaki
|
|
2018
|
24 |
7 |
p. 1441-1448
|
artikel
|
| 24 |
Phase 1/2 Trial of Carfilzomib Plus High-Dose Melphalan Preparative Regimen for Salvage Autologous Hematopoietic Cell Transplantation Followed by Maintenance Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma
|
Costa, Luciano J.
|
|
2018
|
24 |
7 |
p. 1379-1385
|
artikel
|
| 25 |
Post-Transplant CD34+ Selected Stem Cell “Boost” for Mixed Chimerism after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Children and Young Adults with Primary Immune Deficiencies
|
Chandra, Sharat
|
|
2018
|
24 |
7 |
p. 1527-1529
|
artikel
|
| 26 |
Promising Outcome of Umbilical Cord Blood Transplantation in Patients with Multiple Comorbidities
|
Adachi, Yoshitaka
|
|
2018
|
24 |
7 |
p. 1455-1462
|
artikel
|
| 27 |
Prophylaxis for Hepatitis B Virus Reactivation after Allogeneic Stem Cell Transplantation in the Era of Drug Resistance and Newer Antivirals: A Systematic Review and Meta-Analysis
|
Siyahian, Aida
|
|
2018
|
24 |
7 |
p. 1483-1489
|
artikel
|
| 28 |
Refractory Graft-Versus-Host Disease–Free, Relapse-Free Survival as an Accurate and Easy-to-Calculate Endpoint to Assess the Long-Term Transplant Success
|
Kawamura, Koji
|
|
2018
|
24 |
7 |
p. 1521-1526
|
artikel
|
| 29 |
Reversal of T Cell Exhaustion by the First Donor Lymphocyte Infusion Is Associated with the Persistently Effective Antileukemic Responses in Patients with Relapsed AML after Allo-HSCT
|
Liu, Long
|
|
2018
|
24 |
7 |
p. 1350-1359
|
artikel
|
| 30 |
Table of Contents
|
|
|
2018
|
24 |
7 |
p. A16-A22
|
artikel
|
| 31 |
The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future
|
Andermann, Tessa M.
|
|
2018
|
24 |
7 |
p. 1322-1340
|
artikel
|
| 32 |
The Role of Allogeneic Transplantation for Multiple Myeloma in the Era of Novel Agents: A Study from the Japanese Society of Myeloma
|
Kawamura, Koji
|
|
2018
|
24 |
7 |
p. 1392-1398
|
artikel
|
| 33 |
Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study
|
Sengsayadeth, Salyka
|
|
2018
|
24 |
7 |
p. 1406-1414
|
artikel
|
| 34 |
Umbilical Cord Blood Expansion: Are We There Yet?
|
Lund, Troy C.
|
|
2018
|
24 |
7 |
p. 1311-1312
|
artikel
|
| 35 |
Viral Respiratory Tract Infections in Allogeneic Hematopoietic Stem Cell Transplantation Recipients in the Era of Molecular Testing
|
Sim, Starling A.
|
|
2018
|
24 |
7 |
p. 1490-1496
|
artikel
|
Tijdschrift beschrijving